Whitehawk Therapeutics, SES AI, and MIRA Pharmaceuticals are the three Penny stocks to watch today, according to MarketBeat's stock screener tool. Penny stocks are low-priced shares of small public companies that typically trade for less than $5 per share (the SEC’s definition) and are often quoted on over-the-counter markets rather than major exchanges. They usually have low liquidity, wide bid-ask spreads, high volatility and limited public information, making them speculative and higher-risk investments prone to manipulation. These companies had the highest dollar trading volume of any Penny stocks within the last several days.
Whitehawk Therapeutics (WHWK)
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, including tumor agnostic indications targeting specific genomic alterations that activate the mTOR pathway.
Read Our Latest Research Report on WHWK
SES AI (SES)
SES AI Corporation engages in the development and production of high-performance Lithium-metal rechargeable batteries for electric vehicles, electric vehicle take-off and landing, and other applications. The company was founded in 2012 and is headquartered in Woburn, Massachusetts.
Read Our Latest Research Report on SES
MIRA Pharmaceuticals (MIRA)
MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder.
Read Our Latest Research Report on MIRA
Recommended Stories
Before you consider Whitehawk Therapeutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Whitehawk Therapeutics wasn't on the list.
While Whitehawk Therapeutics currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
